Q2 2024 Biogen Inc Earnings Call Transcript
Please stand by for streaming text
Philly from those in our for our agents. We provide a comprehensive list of risk factors in our SEC filings, which I encourage you to review our earnings release and other documents related to our results as well as the reconciliation between GAAP and non-GAAP results discussed on the call can be found in the Investors section at Biogen.com. We have also posted the slides on our website that will be used during this call. On today's call, I'm joined by our President and Chief Executive Officer, Chris Viehbacher, our head in President of North America, Alicia IMO, Dr. Prius single Head of Development, Mike McDonnell, Chief Financial Officer, and will be introducing Dr. Travis Murdoch from high bio on the call. We'll make some opening comments and then we'll move to the Q&A session and to allow us to get through as many questions as possible, we ask that you limit yourself to one question. With that, I'll now turn the call over to Chris.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |